BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deutschman CS, Raj NR, McGuire EO, Kelz MB. Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis. Crit Care Med 2013;41:e368-75. [PMID: 24105451 DOI: 10.1097/CCM.0b013e31828e9843] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Mira JC, Gentile LF, Mathias BJ, Efron PA, Brakenridge SC, Mohr AM, Moore FA, Moldawer LL. Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome. Crit Care Med 2017;45:253-62. [PMID: 27632674 DOI: 10.1097/CCM.0000000000002074] [Cited by in Crossref: 168] [Cited by in F6Publishing: 117] [Article Influence: 33.6] [Reference Citation Analysis]
2 Deutschman CS. Translational Research: The Model Matters. Crit Care Med 2018;46:835-7. [PMID: 29652718 DOI: 10.1097/CCM.0000000000003033] [Reference Citation Analysis]
3 Couvineau A, Voisin T, Nicole P, Gratio V, Abad C, Tan YV. Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases. Front Endocrinol (Lausanne) 2019;10:709. [PMID: 31695678 DOI: 10.3389/fendo.2019.00709] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
4 Boonen E, Van den Berghe G. Understanding the HPA response to critical illness: novel insights with clinical implications. Intensive Care Med 2015;41:131-3. [PMID: 25406407 DOI: 10.1007/s00134-014-3545-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
5 Ogawa Y, Irukayama-Tomobe Y, Murakoshi N, Kiyama M, Ishikawa Y, Hosokawa N, Tominaga H, Uchida S, Kimura S, Kanuka M, Morita M, Hamada M, Takahashi S, Hayashi Y, Yanagisawa M. Peripherally administered orexin improves survival of mice with endotoxin shock. Elife 2016;5:e21055. [PMID: 28035899 DOI: 10.7554/eLife.21055] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
6 Boonen E, Meersseman P, Vervenne H, Meyfroidt G, Guïza F, Wouters PJ, Veldhuis JD, Van den Berghe G. Reduced nocturnal ACTH-driven cortisol secretion during critical illness. Am J Physiol Endocrinol Metab 2014;306:E883-92. [PMID: 24569590 DOI: 10.1152/ajpendo.00009.2014] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
7 Clark IA, Vissel B. Inflammation-sleep interface in brain disease: TNF, insulin, orexin. J Neuroinflammation. 2014;11:51. [PMID: 24655719 DOI: 10.1186/1742-2094-11-51] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
8 Bjekić-Macut J, Radosavljević V, Andrić Z, Ilić D, Stanojlović O, Milutinović DV, Antić IB, Zdravković M, Hinić S, Macut D, Žarković M. Cortisol Response to Low-dose (1 µg) ACTH Stimulation for the Prediction of Outcome in Patients with Systemic Inflammatory Response Syndrome. J Med Biochem 2016;35:428-35. [PMID: 28670195 DOI: 10.1515/jomb-2016-0015] [Reference Citation Analysis]
9 Shimazui T, Nakada TA, Walley KR, Oshima T, Abe T, Ogura H, Shiraishi A, Kushimoto S, Saitoh D, Fujishima S, Mayumi T, Shiino Y, Tarui T, Hifumi T, Otomo Y, Okamoto K, Umemura Y, Kotani J, Sakamoto Y, Sasaki J, Shiraishi SI, Takuma K, Tsuruta R, Hagiwara A, Yamakawa K, Masuno T, Takeyama N, Yamashita N, Ikeda H, Ueyama M, Fujimi S, Gando S; JAAM FORECAST Group. Significance of body temperature in elderly patients with sepsis. Crit Care 2020;24:387. [PMID: 32605659 DOI: 10.1186/s13054-020-02976-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 Deutschman CS, Hellman J, Roca RF, De Backer D, Coopersmith CM; Research Committee of the Surviving Sepsis Campaign. The surviving sepsis campaign: basic/translational science research priorities. Intensive Care Med Exp 2020;8:31. [PMID: 32676795 DOI: 10.1186/s40635-020-00312-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Coopersmith CM, De Backer D, Deutschman CS, Ferrer R, Lat I, Machado FR, Martin GS, Martin-Loeches I, Nunnally ME, Antonelli M, Evans LE, Hellman J, Jog S, Kesecioglu J, Levy MM, Rhodes A. Surviving sepsis campaign: research priorities for sepsis and septic shock. Intensive Care Med 2018;44:1400-26. [PMID: 29971592 DOI: 10.1007/s00134-018-5175-z] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 19.0] [Reference Citation Analysis]
12 Peeters B, Meersseman P, Vander Perre S, Wouters PJ, Debaveye Y, Langouche L, Van den Berghe G. ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study. Intensive Care Med 2018;44:2048-58. [PMID: 30374692 DOI: 10.1007/s00134-018-5427-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
13 Abraham MN, Kelly AP, Brandwein AB, Fernandes TD, Leisman DE, Taylor MD, Brewer MR, Capone CA, Deutschman CS. Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future Studies. Shock 2020;54:168-82. [PMID: 31764625 DOI: 10.1097/SHK.0000000000001485] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
14 Nunnally ME, Ferrer R, Martin GS, Martin-Loeches I, Machado FR, De Backer D, Coopersmith CM, Deutschman CS; Surviving Sepsis Campaign Reasearch Committee. The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsis. Intensive Care Med Exp 2021;9:34. [PMID: 34212256 DOI: 10.1186/s40635-021-00400-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Modi HR, Wang Q, Gd S, Sherman D, Greenwald E, Savonenko AV, Geocadin RG, Thakor NV. Intranasal post-cardiac arrest treatment with orexin-A facilitates arousal from coma and ameliorates neuroinflammation. PLoS One 2017;12:e0182707. [PMID: 28957432 DOI: 10.1371/journal.pone.0182707] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
16 Pavlov VA, Chavan SS, Tracey KJ. Molecular and Functional Neuroscience in Immunity. Annu Rev Immunol 2018;36:783-812. [PMID: 29677475 DOI: 10.1146/annurev-immunol-042617-053158] [Cited by in F6Publishing: 136] [Reference Citation Analysis]
17 Couvineau A, Voisin T, Nicole P, Gratio V, Blais A. Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions. World J Gastroenterol 2021; 27(44): 7582-7596 [PMID: 34908800 DOI: 10.3748/wjg.v27.i44.7582] [Reference Citation Analysis]